Brief: Medipal Holdings Announces European Commission Granted Orphan Drug Designation To JR-446
24/06/2025 20:40
June 24 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T: MEDIPAL HOLDINGS : ANNOUNCED EUROPEAN COMMISSION GRANTED ORPHAN DRUG DESIGNATION TO JR-446 Source text: ID:nBw4RVq6Ha Further company coverage: 4552.T ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medipal Holdings
See all newsBrief: Medipal Holdings Corp Says It Will Buy Back Up To 2% Of Own Shares Worth 10 Billion Yen
Table: Medipal Holdings -2026/27 group forecast
Brief: Medipal Holdings Announces It Has Received Demand For EGM From Shareholder Silchester International Investors
Brief: Silchester International Raises Stake In Medipal Holdings Corp To 11.96% From 11.73%, Filing Shows
Brief: Silchester To Make Proposals Regarding Higher Dividend, Share Buyback, Share Retirement, Composition Of Board Of Directors If No Improvement In Dialogue With Medipal Holdings, Filing Shows